History
Cryohealthcare was among the first companies to bring Cryotherapy to the United States in 2009. Medical Director and Co-Founder Jonas Kuehne, M.D. graduated from UCLA School of Medicine ('03) and was the first physician to introduce this treatment in Northern America with the company's headquarter in Los Angeles, CA. Dr. Kuehne developed and trademarked the CryofacialTM treatment and set standards in treatment efficacy and safety since their introduction. In 2011 Cryohealthcare added an engineering department to the company headed by Sr. Mechanical Engineer Paul Sauer to co-develop the leading standard of cryotherapy equipment. As a result, Cryohealthcare became the official and nationwide distributor of the world's leading cryotherapy equipment with distribution in the U.S., Canada, Mexico, and Germany. In 2013, Cryohealthcare re-branded its operation under Cryomachines Inc and opened offices in Canada and Germay, focusing on dirstibution and premier service of its devices.
Specialties
With Whole Body Cryotherapy (WBC) the body is exposed to ultra-low temperatures, triggering a systemic anti-inflammatory response. This modality was first utilized in Japan in 1978 to treat rheumatoid arthritis. Studies conducted in Europe over the last two decades have established WBC as a powerful treatment for inflammatory disorders and injuries. The treatments have been used to accelerate the production of collagen, to improve skin elasticity and texture, to reverse skin aging, and to reduce the appearance of cellulite. WBC boosts the body's metabolic rate, which accelerates weight loss outcomes. Professional athletes have discovered WBC as a powerful treatment to decrease recovery time and increase athletic performance.